N/A
N=39
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Nutritional and Metabolic Diseases
Bottom Line
View on ClinicalTrials.gov: NCT02683876 ↗Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Differences in Metabolite Concentrations in Urine Between Individuals With Malodor Issues and Age-matched Healthy Controls. — 3.4; 8.6; 0.443; 0.8 uMol/mM creatinine
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mebo Research, Inc.
- Primary completion
- Aug 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Differences in Metabolite Concentrations in Urine Between Individuals With Malodor Issues and Age-matched Healthy Controls. |
3.4; 8.6; 0.443; 0.8; 4.0; 3.0 | — |
| SECONDARY Correlations Between Urine Biomarkers and Frequency/Severity of Malodor Symptoms (Questionnaires) |
3; 3; 0.5; 0.4; 4; 3 | — |
Summary
The purpose of this study is to identify metabolic signatures associated with malodor conditions. The investigators will perform state-of-the art metabolomics tests and bioinformatic data mining to explore if conditions leading to malodor can be screened by metabolomic profiling of urine samples.
Eligibility Criteria
Inclusion Criteria
- 18 years or older
- unpredictable and uncontrollable episodes of malodor
- willing and able to ship a urine sample (in the kit provided) by an overnight courier to Edmonton, Alberta, Canada
- good general health
Exclusion Criteria
- serious medical conditions that require treatment
- conditions that, in the opinion of the investigator, would prevent participation
- under the age of 18
- elect not to participate in the study
Data sourced from ClinicalTrials.gov (NCT02683876). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.